Talazoparib Drug Interactions
Currently displaying a list of 304 drugs known to interact with talazoparib.
- 53 major drug interactions
- 251 moderate drug interactions
Medications known to interact with talazoparib
Note: Showing generic names only.
A
- abiraterone
- abrocitinib
- acalabrutinib
- adalimumab
- adenovirus vaccine
- afatinib
- alefacept
- alemtuzumab
- alpelisib
- amiodarone
- anakinra
- anthrax vaccine adsorbed
- apremilast
- asciminib
- atezolizumab
- atorvastatin
- avacopan
- avelumab
- azathioprine
- azithromycin
B
- baricitinib
- bcg
- bcg vaccine
- bepridil
- berotralstat
- bifidobacterium infantis
- bifidobacterium longum
- boceprevir
- brewer's yeast
C
- cabozantinib
- canakinumab
- candida albicans extract
- capmatinib
- captopril
- carvedilol
- cemiplimab
- ceritinib
- certolizumab
- chikungunya vaccine, live (cvx 317)
- chikungunya vaccine, recombinant (cvx 329)
- chloramphenicol
- chloramphenicol ophthalmic
- chloramphenicol otic
- cholera vaccine
- cholera vaccine, live
- cladribine
- clarithromycin
- clozapine
- cobicistat
- coccidioidin skin test
- conivaptan
- cosibelimab
- COVID-19 mRNA (Moderna) vaccine
- COVID-19 mRNA (Pfizer) vaccine
- crizotinib
- cyclosporine
D
- daclatasvir
- danicopan
- daridorexant
- darolutamide
- darunavir
- deferiprone
- delavirdine
- dengue vaccine
- denosumab
- deucravacitinib
- diltiazem
- dimethyl fumarate
- diroximel fumarate
- dostarlimab
- dronedarone
- durvalumab
E
- efalizumab
- efbemalenograstim alfa
- eflapegrastim
- elacestrant
- elagolix
- eliglustat
- eltrombopag
- eluxadoline
- enasidenib
- encorafenib
- entrectinib
- erythromycin
- etanercept
- etrasimod
- ezogabine
F
G
H
- haemophilus b conjugate (hboc) vaccine
- haemophilus b conjugate (prp-omp) vaccine
- haemophilus b conjugate (prp-t) vaccine
- hepatitis a adult vaccine
- hepatitis a pediatric vaccine
- hepatitis b adult vaccine
- hepatitis b pediatric vaccine
- histoplasmin
- human papillomavirus vaccine
- hydroxychloroquine
I
- ibrutinib
- idelalisib
- indinavir
- infliximab
- influenza virus vaccine, h1n1, inactivated
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, h5n1
- influenza virus vaccine, inactivated
- influenza virus vaccine, live
- ipilimumab
- isavuconazonium
- itraconazole
- ivacaftor
- ivosidenib
J
K
L
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- lapatinib
- lazertinib
- leflunomide
- lenacapavir
- leniolisib
- levacetylleucine
- levoketoconazole
- lomitapide
- loncastuximab tesirine
- lovastatin
- lyme disease vaccine
M
- maribavir
- mavorixafor
- measles virus vaccine
- meningococcal conjugate vaccine
- meningococcal group acwy conjugate-group b vaccine (cvx 316)
- meningococcal group B vaccine
- meningococcal polysaccharide vaccine
- mibefradil
- midostaurin
- mifepristone
- mirabegron
- mitapivat
- mixed respiratory vaccine
- momelotinib
- monomethyl fumarate
- mumps skin test antigen
- mumps virus vaccine
N
O
P
- pacritinib
- palbociclib
- palifermin
- pegfilgrastim
- pembrolizumab
- pemigatinib
- pertussis, acellular
- pirtobrutinib
- plague vaccine
- pneumococcal 13-valent vaccine
- pneumococcal 15-valent conjugate vaccine
- pneumococcal 20-valent conjugate vaccine
- pneumococcal 21-valent conjugate vaccine
- pneumococcal 23-polyvalent vaccine
- pneumococcal 7-valent vaccine
- poliovirus vaccine, inactivated
- poliovirus vaccine, live, trivalent
- ponatinib
- ponesimod
- posaconazole
- pralsetinib
- pretomanid
- propafenone
Q
R
- rabies vaccine, human diploid cell
- rabies vaccine, purified chick embryo cell
- radium 223 dichloride
- ranolazine
- regorafenib
- reserpine
- resmetirom
- retifanlimab
- ribociclib
- rilonacept
- ripretinib
- ritlecitinib
- ritonavir
- roflumilast
- rolapitant
- ropeginterferon alfa-2b
- rotavirus vaccine
- rsv vaccine pref3, recombinant
- rsv vaccine, mrna
- rsv vaccine, pref a-pref b, recombinant
- rubella virus vaccine
- rucaparib
S
- saccharomyces boulardii lyo
- safinamide
- samarium sm 153 lexidronam
- saquinavir
- sargramostim
- sars-cov-2 (covid-19) ad26 vaccine, recombinant
- sars-cov-2 (covid-19) chadox1 vaccine, recombinant
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 308)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 309)
- sars-cov-2 (covid-19) mrna-lnp vaccine (cvx 310)
- sars-cov-2 (covid-19) nvx-cov2373 vaccine, recombinant
- sars-cov-2 (covid-19) rs-nanoparticle vaccine, recombinant
- sars-cov-2 mrna (tozinameran 5y-11y) vaccine
- sars-cov-2 mrna (tozinameran 6m-4y) vaccine
- sars-cov-2 mrna (tozinameran-tris-sucrose) vaccine
- sars-cov-2 mrna (tozinameran) vaccine
- sars-cov-2 mrna-1273 (6m-5y) vaccine
- sars-cov-2 mrna-1273 (6y-11y) vaccine
- sars-cov-2 mrna-1273 (booster only) vaccine
- sars-cov-2 nvx-cov2373 vaccine, recomb (cvx 313)
- sars-cov-2 pres dtm (booster only) vaccine, recombinant
- selpercatinib
- simeprevir
- simvastatin
- siponimod
- sipuleucel-T
- skin test antigens, multiple
- smallpox and mpox vaccine
- smallpox vaccine
- sodium phosphate p32
- sorafenib
- sotorasib
- sparsentan
- spironolactone
- staphage lysate (spl)
- streptococcus salivarius
- strontium-89 chloride
- suvorexant
T
- tacrolimus
- talimogene laherparepvec
- tamoxifen
- tbo-filgrastim
- tedizolid
- telaprevir
- telithromycin
- tepotinib
- teriflunomide
- tetanus toxoid
- ticagrelor
- tick-borne encephalitis (inactivated) pediatric vaccine
- tick-borne encephalitis (inactivated) vaccine
- tipranavir
- tislelizumab
- tivozanib
- tofacitinib
- tolvaptan
- topotecan
- toripalimab
- tremelimumab
- treosulfan
- trichophyton skin test
- tuberculin purified protein derivative
- tucatinib
- turmeric
- typhoid vaccine, inactivated
- typhoid vaccine, live
U
V
- vadadustat
- valbenazine
- valganciclovir
- vandetanib
- varicella virus vaccine
- vemurafenib
- venetoclax
- verapamil
- vimseltinib
- voclosporin
Y
Z
Talazoparib disease interactions
There are 3 disease interactions with talazoparib which include:
More about talazoparib
- talazoparib consumer information
- Check interactions
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: PARP inhibitors
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.